Synchrogenix, Certara’s Regulatory and Medical Writing Consultancy, Acquires ClinGenuity

Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that its regulatory and medical consultancy, Synchrogenix, has acquired ClinGenuity, the only artificial intelligence-assisted medical writing service in the pharmaceutical industry.



from Content Keyword RSS http://ift.tt/1wiKKMc

via IFTTT